Literature DB >> 17289663

Glucose-stimulated Cdc42 signaling is essential for the second phase of insulin secretion.

Zhanxiang Wang1, Eunjin Oh, Debbie C Thurmond.   

Abstract

The small Rho family GTPases Cdc42 and Rac1 have each been shown to function in insulin exocytosis and are presumed to function in actin remodeling and insulin granule mobilization. However, whether either GTPase is required for the mobilization phase of insulin release (second phase) and are linked in a common signaling pathway has remained unknown. Here we demonstrate that small interfering RNA-mediated depletion of Cdc42 from isolated islets results in the selective loss of second phase insulin release. Consistent with a role in this nutrient-dependent phase, Cdc42 activation was detected exclusively in response to D-glucose and was unresponsive to KCl or non-metabolizable glucose analogs in MIN6 beta-cells. Cdc42 activation occurred early in secretion (3 min), whereas Rac1 activation required approximately 15-20 min, suggesting Cdc42 as proximal and Rac1 as distal regulators of second-phase secretion. Importantly, Rac1 activation and function was linked in a common pathway downstream of Cdc42; Cdc42 depletion ablated glucose-induced Rac1 activation, and expression of constitutively active Rac1 in Cdc42-depleted cells functionally restored glucose-stimulated insulin secretion. Occurring at a time midway between Cdc42 and Rac1 activations was the phosphorylation of p21-activated-kinase 1 (Pak1), and this phosphorylation event required Cdc42. Moreover, small interfering RNA-mediated Pak1 depletion abolished Rac1 activation and glucose-stimulated insulin release, suggesting that Pak1 may mediate the link between Cdc42 and Rac1 in this pathway. Taken together, these data substantiate the existence of a novel signaling pathway in the islet beta-cell whereby Cdc42 functions as a key proximal transmitter of the glucose signal early in stimulus-secretion coupling to support the later stage of insulin release.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17289663      PMCID: PMC2396332          DOI: 10.1074/jbc.M610553200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  44 in total

1.  Gluco-incretins control insulin secretion at multiple levels as revealed in mice lacking GLP-1 and GIP receptors.

Authors:  Frédéric Preitner; Mark Ibberson; Isobel Franklin; Christophe Binnert; Mario Pende; Asllan Gjinovci; Tanya Hansotia; Daniel J Drucker; Claes Wollheim; Rémy Burcelin; Bernard Thorens
Journal:  J Clin Invest       Date:  2004-02       Impact factor: 14.808

2.  Method for the isolation of intact islets of Langerhans from the rat pancreas.

Authors:  P E Lacy; M Kostianovsky
Journal:  Diabetes       Date:  1967-01       Impact factor: 9.461

3.  Novel regulation by Rac1 of glucose- and forskolin-induced insulin secretion in INS-1 beta-cells.

Authors:  Jingsong Li; Ruihua Luo; Anjaneyulu Kowluru; GuoDong Li
Journal:  Am J Physiol Endocrinol Metab       Date:  2004-01-21       Impact factor: 4.310

4.  Insulin resistance in tetracycline-repressible Munc18c transgenic mice.

Authors:  Beth A Spurlin; Rhonda M Thomas; Angela K Nevins; Hyo-Jeong Kim; Yoon-Jung Kim; Hye-Lim Noh; Gerald I Shulman; Jason K Kim; Debbie C Thurmond
Journal:  Diabetes       Date:  2003-08       Impact factor: 9.461

5.  Phosphorylation of RhoGDI by Pak1 mediates dissociation of Rac GTPase.

Authors:  Céline DerMardirossian; Andreas Schnelzer; Gary M Bokoch
Journal:  Mol Cell       Date:  2004-07-02       Impact factor: 17.970

6.  Glucose regulates the cortical actin network through modulation of Cdc42 cycling to stimulate insulin secretion.

Authors:  Angela K Nevins; Debbie C Thurmond
Journal:  Am J Physiol Cell Physiol       Date:  2003-05-21       Impact factor: 4.249

7.  Antagonistic cross-talk between Rac and Cdc42 GTPases regulates generation of reactive oxygen species.

Authors:  Becky A Diebold; Bruce Fowler; Justine Lu; Mary C Dinauer; Gary M Bokoch
Journal:  J Biol Chem       Date:  2004-05-03       Impact factor: 5.157

8.  Novel regulatory mechanisms for the Dbl family guanine nucleotide exchange factor Cool-2/alpha-Pix.

Authors:  Qiyu Feng; Daniel Baird; Richard A Cerione
Journal:  EMBO J       Date:  2004-08-12       Impact factor: 11.598

9.  Regulated exocytosis in neuroendocrine cells: a role for subplasmalemmal Cdc42/N-WASP-induced actin filaments.

Authors:  Stéphane Gasman; Sylvette Chasserot-Golaz; Magali Malacombe; Michael Way; Marie-France Bader
Journal:  Mol Biol Cell       Date:  2003-11-14       Impact factor: 4.138

10.  ADP-ribosylation factor 6 regulates insulin secretion through plasma membrane phosphatidylinositol 4,5-bisphosphate.

Authors:  John T R Lawrence; Morris J Birnbaum
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-29       Impact factor: 11.205

View more
  85 in total

1.  Synapses of amphids defective (SAD-A) kinase promotes glucose-stimulated insulin secretion through activation of p21-activated kinase (PAK1) in pancreatic β-Cells.

Authors:  Jia Nie; Chao Sun; Omar Faruque; Guangming Ye; Jia Li; Qiangrong Liang; Zhijie Chang; Wannian Yang; Xiao Han; Yuguang Shi
Journal:  J Biol Chem       Date:  2012-06-05       Impact factor: 5.157

2.  Arf nucleotide binding site opener [ARNO] promotes sequential activation of Arf6, Cdc42 and Rac1 and insulin secretion in INS 832/13 β-cells and rat islets.

Authors:  Bhavaani Jayaram; Ismail Syed; Chandrashekara N Kyathanahalli; Christopher J Rhodes; Anjaneyulu Kowluru
Journal:  Biochem Pharmacol       Date:  2011-01-26       Impact factor: 5.858

3.  EHT 1864, a small molecule inhibitor of Ras-related C3 botulinum toxin substrate 1 (Rac1), attenuates glucose-stimulated insulin secretion in pancreatic β-cells.

Authors:  Vaibhav Sidarala; Rajakrishnan Veluthakal; Khadija Syeda; Anjaneyulu Kowluru
Journal:  Cell Signal       Date:  2015-02-26       Impact factor: 4.315

Review 4.  Epac2-dependent rap1 activation and the control of islet insulin secretion by glucagon-like peptide-1.

Authors:  Colin A Leech; Oleg G Chepurny; George G Holz
Journal:  Vitam Horm       Date:  2010       Impact factor: 3.421

Review 5.  Bridging the gap between protein carboxyl methylation and phospholipid methylation to understand glucose-stimulated insulin secretion from the pancreatic beta cell.

Authors:  Anjaneyulu Kowluru
Journal:  Biochem Pharmacol       Date:  2007-06-28       Impact factor: 5.858

6.  PPARβ/δ affects pancreatic β cell mass and insulin secretion in mice.

Authors:  José Iglesias; Sebastian Barg; David Vallois; Shawon Lahiri; Catherine Roger; Akadiri Yessoufou; Sylvain Pradevand; Angela McDonald; Claire Bonal; Frank Reimann; Fiona Gribble; Marie-Bernard Debril; Daniel Metzger; Pierre Chambon; Pedro Herrera; Guy A Rutter; Marc Prentki; Bernard Thorens; Walter Wahli
Journal:  J Clin Invest       Date:  2012-10-24       Impact factor: 14.808

7.  A common functional regulatory variant at a type 2 diabetes locus upregulates ARAP1 expression in the pancreatic beta cell.

Authors:  Jennifer R Kulzer; Michael L Stitzel; Mario A Morken; Jeroen R Huyghe; Christian Fuchsberger; Johanna Kuusisto; Markku Laakso; Michael Boehnke; Francis S Collins; Karen L Mohlke
Journal:  Am J Hum Genet       Date:  2014-01-16       Impact factor: 11.025

8.  The adaptor protein APPL2 controls glucose-stimulated insulin secretion via F-actin remodeling in pancreatic β-cells.

Authors:  Baile Wang; Huige Lin; Xiaomu Li; Wenqi Lu; Jae Bum Kim; Aimin Xu; Kenneth K Y Cheng
Journal:  Proc Natl Acad Sci U S A       Date:  2020-10-29       Impact factor: 11.205

Review 9.  Mechanisms of biphasic insulin-granule exocytosis - roles of the cytoskeleton, small GTPases and SNARE proteins.

Authors:  Zhanxiang Wang; Debbie C Thurmond
Journal:  J Cell Sci       Date:  2009-04-01       Impact factor: 5.285

10.  A p21-activated kinase (PAK1) signaling cascade coordinately regulates F-actin remodeling and insulin granule exocytosis in pancreatic β cells.

Authors:  Michael A Kalwat; Stephanie M Yoder; Zhanxiang Wang; Debbie C Thurmond
Journal:  Biochem Pharmacol       Date:  2012-12-16       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.